Posted On: 09/17/2015 12:09:42 PM
Post# of 72447
Some interesting stuff from BioHedge over there.
"My birds have been telling me of significant meetings happening (or have happened) between leo and C level execs at a company I'd love to have Cellceutix sell to. The catalyst was a deep interest in Kevetrin's progress and results."
Who wouldn't want a p53-activating drug with a strong safety profile?
"My birds have been telling me of significant meetings happening (or have happened) between leo and C level execs at a company I'd love to have Cellceutix sell to. The catalyst was a deep interest in Kevetrin's progress and results."
Who wouldn't want a p53-activating drug with a strong safety profile?
(0)
(0)
